The role of MiRNA 122 and 494 as a Liquid Biopsy Markers for the Diagnostic Patients with the end Stages of Hepatocellular Carcinoma in Iraq | [Pakistan Journal of Life and Social Sciences • 2024]

Author(s):

1. Ruqia Imran Kareem: College of Medicine, Department of Pathology al-Qadisiyah University,,Iraq

2. Wijdan Thamir Mahdi: College of Medicine, Department of Pathology al-Qadisiyah University, Iraq.

3. Aws Rassul Hussain: College of Medicine, Department of Pathology al-Qadisiyah University,,Iraq

Abstract:

Hepatocellular Carcinoma (HCC) Disease is the most popular and widespread kind of the liver cancer, It constitutes about 90% of occurrences; This disease has become a source of fear and an increasing danger to public health, as it ranks as the 4 largest cause of death worldwide at the moment. Evaluation of possibility of using miRNA122 and miRNA494 as predictive factors for the incidence of HCC disease in infected patients at the Oncology Center at the diwaniya Teaching Hospital and the Middle Euphrates Oncology Center in Najaf. Our present investigation was established in the Middle Euphrates Oncology Hospital and the Al-diwaniayh Oncology Center in Najaf. Sample collection took place between January and November of 2023. 44 individuals were selected as the patient group, and 44 uninfected people were chosen as the control group. The mean age of patients diagnosed with HCC was 65.13 ± 6.74 years, whereas in the control group was 60.70 ± 10.48 years. Based on these data, it was determined there is no difference in morale statistically in morality in both groups (P = 0.103). The study found that patients who suffer from HCC substantially reduced levels of miRNA-122 gene expression compared to control (0.102 ± 0.024 vs 1.16 ± 0.217, respectively, However, miRNA-494 gene expression was considerably greater in HCC patients compared to healthy controls (20.24 ± 2.56 vs 1.26 ± 0.88, respectively, P< 0.001). By using the ROC analysis , Our findings illustrate that both biomarkers that used in our current study it has a predictive value for the incidence of HCC and therefore it can be used as a liquid biopsy markers for the Diagnostic patients with for the detection or early diagnosis of the HCC .

Page(s): 2175-2183

DOI: 10.57239/PJLSS-2024-22.1.00160

Published: Journal: Pakistan Journal of Life and Social Sciences, Volume: 22, Issue: 1, Year: 2024

Keywords:

Liver HCC miRNA Liquid Biopsy Markers Gene Expression

References:

[1] Wu X .,Tang H.,Guan A.,Sun F.,Wang H.,Shu J. .2016 .Finding gastric cancer related genes and clinical biomarkers for detection based on gene-gene interaction network. Mathematical Biosciences, 276 : 1-7.

[2] .2022 .Data Visualization Tools for Exploring the Global Cancer Burden in. accessed on 1 September, : .

[3] Chou ,C.-H.; Shrestha S.,Yang S.,C.-D. S.,Chang S.,Lin Y.-L.,Liao Y.-L.,Sun Y.-L.,Lee W.-H. .2018 .A resource for experimentally validated microRNA-target interactions. Nucleic Acids Res, 46 : D296-D302.

[4] Yin S,Fan Y,Zhang H,Zhao Z,Hao Y,Li J,Sun C,Yang J,Yang Z,Yang X,Lu J,Xi JJ .2016 .Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun, 7 : 11012.

[5] Zheng X,Wang G,Yuan J,Li N,Yan B,Yan J,Sheng Y. .2022 .. hsa-miR-34a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury Via Targeting HNF4α. Turk J Gastroenterol, 33 : 596-605.

[6] Rheault M,Cousineau SE,Fox DR,Abram QH,Sagan SM .2023 .Elucidating the distinct contributions of miR122 in the HCV life cycle reveals insights into virion assembly. Nucleic Acids Res, 51 : 2447-2463.

[7] Sayiner M,Golabi P,Younossi ZM .2019 .. Disease Burden of Hepatocellular Carcinoma: A Global Perspective 2019. Dig Dis Sci, 64(4) : 910-917.

[8] Kunden RD,Khan JQ,Ghezelbash S .2020 .The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle. Int J Mol Sci, 21(16) : 5677.

[9] Xu G,Bu S,Wang X,Ge H. MiR X .2022 .-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin G1. Int J Radiat Biol, 98(1) : 11-17.

[10] Parizadeh SM,Jafarzadeh-Esfehani R,Ghandehari M Goldani F,Parizadeh SM,Hassanian SM,Ghayour-Mobarhan M .2019 .MicroRNAs as potential diagnostic and prognostic biomarkers in hepatocellular carcinoma. Current Drug Targets, 20(11) : 1129-1140.

[11] Huang A,Yang XR,Chung WY,Dennison AR,Zhou J. .2020 .Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther, 5(1) : 1-13.

[12] Shen PF,Chen XQ,Liao YC,Chen N,Zhou Q,Wei Q,Li X,Wang J,Zeng H. .2014 .MicroRNA 494 3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate, 74 : 756.

[13] Pollutri D.,Patrizi C.,Marinelli S.,Giovannini C.,Trombetta E.,Giannone F. A.,Fornari F. .2018 .The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma. Cell death & disease, 9(1), : 4.

[14] Bergamini C.,Leoni I.,Rizzardi N.,Melli M.,Galvani G.,Coada C. A.,Fornari F. .2023 .MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research, 42(1) : 145.

[15] Tang G.,Shen X.,Lv K.,Wu Y.,Bi J.,Shen Q. .2015 .Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Medical science monitor: international medical journal of experimental and clinical research, 21 : 617.

[16] Livak K. J.,Schmittgen T. D. .2001 .Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. , 25(4) : 402-408.

[17] Daniel W.W. .2018 .Biostatistics: A Foundation for Analysis in the Health Sciences. , : .

[18] Baraka K.,Abozahra R. R.,Badr E.,Abdelhamid S. M. .2023 .Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC. BMC cancer, 23(1) : 938.

[19] Thabet A. N. E. D.,Abul-Hasan E. F.,Arafa O. A.,Fattouh M. A. .2023 .Possible diagnostic role of microRNA-122 in chronic HCV infection and hepatocellular carcinoma. Microbes and Infectious Diseases, 4(2) : 436-449.

[20] Pratama M. Y.,Pascut D.,Massi M. N.,Tiribelli C. .2019 .The role of microRNA in the resistance to treatment of hepatocellular carcinoma. Annals of translational medicine, 7(20) : .

[21] Gao X.,Yang X.,He F.,Liu X.,Liu D.,Yuan X. .2023 .Downregulation of microRNA 494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA α mediated apoptosis. Experimental and Therapeutic Medicine, 25(6) : 1-9.

Citations

Downloads

Views